Laurence Klotz, MD, FRCSC
Editor

2012

On 21 May 2012, the US Preventive Services Task Force announced its final recommendation for PSA screening: “Level D,” “moderate or high certainty that the service has no benefit or that the harms outweigh the benefits.” This sent shock waves through the prostate cancer community.